Critically Ill — Managing Acute Pain in Critically Ill Non-communicative Palliative Care Patients
Citation(s)
McGuire DB. The multidimensional phenomenon of cancer pain. In: McGuire DB, Yarbro CH, eds. Cancer Pain Management. Orlando, FL: Grune and Stratton 1-20, 1987.
Shadish WR, Cook TD, Campbell DT. Experimental and Quasi-experimental Designs for Generalized Causal Inference. Belmont, CA: Wadsworth; 2002.
Acute Pain Management Guideline Panel Acute pain management: operative or medical procedures and trauma. Clinical practice guideline Publ No. 92-0032. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services; 1992.
Ahles TA, Blanchard EB, Ruckdeschel JC The multidimensional nature of cancer-related pain. Pain. 1983 Nov;17(3):277-288. doi: 10.1016/0304-3959(83)90100-8.
Arbour C, Gélinas C Are vital signs valid indicators for the assessment of pain in postoperative cardiac surgery ICU adults? Intensive Crit Care Nurs. 2010 Apr;26(2):83-90. doi: 10.1016/j.iccn.2009.11.003. Epub 2009 Dec 30.
Cohen SP, Christo PJ, Moroz L Pain management in trauma patients. Am J Phys Med Rehabil. 2004 Feb;83(2):142-61. Review.
Downing,MG Palliative Performance Scale (PPSv3) version 2. Learning Center for Palliative Care. Victoria, BC. 2005.
Foley K Acute and chronic cancer pain syndromes. Chapter 8.2.2. In: Doyle D, Hanks G, Cherney NI, Calman K, eds. Oxford Textbook of Palliative Medicine 3rd ed. New York, NY: Oxford University Press 298-316, 2005.
Gil Z, Smith DB, Marouani N, Khafif A, Fliss DM Treatment of pain after head and neck surgeries: control of acute pain after head and neck oncological surgeries. Otolaryngol Head Neck Surg. 2006 Aug;135(2):182-8.
Health Care Cost and Utilization Project (HCUP) Clinical Classifications Software (CCS) for ICD-9-CM. http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp#overview. Updated Jan 25, 2011. Accessed March 20, 2011.
Herr K, Bjoro K, Decker S Tools for assessment of pain in nonverbal older adults with dementia: a state-of-the-science review. J Pain Symptom Manage. 2006 Feb;31(2):170-92. Review.
Johnston CC Psychometric issues in the measurement of pain. In: Finley GA, McGrath PJ, eds. Measurement of Pain in Children and Infants. Seattle, WA: IASP Press 5-20, 1998.
Kaiser K, Dupee J, Petri L, Hill J, Smith D Application of selected 2008 American pain society quality indicators for acute and chronic pain. Journal of Pain 8(4):S1-S70, 2007.
Kaiser K Use of electronic medical records in pain management In: Pasero C, McCaffery M. Pain Assessment and Pharmacologic Management. Baltimore, MD: Mosby 837-857, 2011.
Kessler SM, Swetz KM Prognostication in severe traumatic brain injury in adults. http://www.eperc.mcw.edu/fastFact/ff_239.htm. Accessed March 20, 2011.
Malchow RJ, Black IH The evolution of pain management in the critically ill trauma patient: Emerging concepts from the global war on terrorism. Crit Care Med. 2008 Jul;36(7 Suppl):S346-57. doi: 10.1097/CCM.0b013e31817e2fc9. Review.
McGuire DB, Kaiser K, Soeken K, Reifsnyder J, Keay T Measuring pain in noncommunicative palliative care patients in the acute care setting: Psychometric evaluation of the multidimensional objective pain assessment tool (MOPAT). Journal of Pain and Symptom Management 41(1):299-300, 2011.
McGuire DB Occurrence of cancer pain. J Natl Cancer Inst Monogr. 2004;(32):51-6. Review.
McGuire DB The multiple dimensions of cancer pain: a framework for assessment and management. In: McGuire DB, Yarbro CH, Ferrell BR, eds. Cancer Pain Management 2nd ed. Boston, MA: Jones and Bartlett Publishers; 1-17: 1995.
Melzack R, Casey KL Sensory, Motivational, and Central Control Determinants of Pain: A New Conceptual Model. Kenshalo D. (Ed.). Chas C. Thomas. Springfield, MA; 423-439, 1968.
National Priorities Partnership (NPP) National Priorities and Goals: Aligning our Efforts to Transform America's Healthcare. Washington, DC: National Quality Forum; 2008.
National Quality Forum (NQF) A National Framework and Preferred Practices for Palliative and Hospice Care Quality. Washington DC: Author; 2006.
Paice JA, Muir JC, Shott S Palliative care at the end of life: comparing quality in diverse settings. Am J Hosp Palliat Care. 2004 Jan-Feb;21(1):19-27.
Perreault SD Chromatin remodeling in mammalian zygotes. Mutat Res. 1992 Dec;296(1-2):43-55. Review.
Prescott PA, Soeken KL The potential uses of pilot work. Nurs Res. 1989 Jan-Feb;38(1):60-2.
Reyna YZ, Bennett MI, Bruera E Ethical and practical issues in designing and conducting clinical trials in palliative care. In: Addington-Hall JM, Bruera E, Higginson IJ, Payne S, eds. Research Methods in Palliative Care. New York, NY: Oxford; 27-38, 2009.
Reynolds CM, Suber F, Curtis KM, Henriques HF A novel pain management protocol results in more rapid analgesia for trauma patients. Society for Academy of Emergency Medicine 11(5):497, 2004.
Sessler CN, Grap MJ, Ramsay MA Evaluating and monitoring analgesia and sedation in the intensive care unit. Crit Care. 2008;12 Suppl 3:S2. doi: 10.1186/cc6148. Epub 2008 May 14. Review.
Virik K, Glare P Validation of the palliative performance scale for inpatients admitted to a palliative care unit in Sydney, Australia. J Pain Symptom Manage. 2002 Jun;23(6):455-7.
Walker KA, Nachreiner D, Patel J, Mayo RL, Kearney CD Impact of standardized palliative care order set on end-of-life care in a community teaching hospital. J Palliat Med. 2011 Mar;14(3):281-6. doi: 10.1089/jpm.2010.0398.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.